Atlas Trials

A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease

Clinical trial NCT01458288 · COMPLETED

Trial details

NCT number
NCT01458288
Sponsor
GPCR Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaNon-hodgkin's LymphomaHodgkin's Disease
Start date
2012-10-01
Primary completion
2013-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.